Problems of Radiation Medicine and Radiobiology

I. V. Abramenko, N. I. Bilous, A. A. Chumak, I. S. Diagil, Z. V. Martina

State Institution «National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine», 53 Yuriia Illienka Str., Kyiv, 04050, Ukraine

THE EXPRESSION OF THE MAIN AND ALTERNATIVE TRANSCRIPT (SORL1-Δ2) OF THE SORL1 GENE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS AFFECTED BY THE CHORNOBYL ACCIDENT

Objective: to study clinical-hematological data and expression of the main and alternative transcripts of SORL1 gene in chronic lymphocytic leukemia (CLL) patients affected by the Chornobyl catastrophe.
Methods. Analysis was performed in the main group of 34 CLL patients irradiated due to the Chornobyl NPP accident (30 clean-up workers, and 4 evacuees) and in the control group of 27 non-irradiated CLL patients. Groups of patients were comparable by age, sex, stage of disease, mutational status of IGHV genes. Expression of the main and alternative transcripts of SORL1 gene was evaluated by Quantitative Real-time polymerase chain reaction (PCR). The IGHV gene mutational status, TP53 and SF3B1 mutations were studied by PCR followed by direct sequencing. Data were analyzed with the SPSS software package, version 20.0.
Results. Relative expression level of the main transcript of SORL1 gene was low (mean 1.71 ± 0.55, median 0.57), did not correlate with the IGHV gene mutational status, TP53 and SF3B1 mutations, stage of disease. The expression of B transcript was not detected, F transcript was expressed at a very low level in 9 patients. The average relative expression level of SORL1-Δ2 transcript was 14.1 ± 6.04 (median 3.48; range 0.01–90.51). The expression of SORL1-Δ2 transcript above the median was more frequent among patients on C stage (p = 0.001), and in patients with unmutated IGHV genes was associated with an extremely negative course of CLL (median of overall survival 9 months vs 61 months at low expression). Relative expression levels of the main and alternative transcripts of SORL1 gene in patients of the main and the control groups did not differ.
Conclusions. Our preliminary data suggest that increased expression of SORL1-Δ2 transcript in CLL patients with unmutated IGHV genes can be considered as a negative prognostic marker.
Key words: chronic lymphocytic leukemia, SORL1, SORL1-Δ2, Chornobyl NPP accident.

Problems of Radiation Medicine and Radiobiology.
021;26:273-283. doi: 10.33145/2304-8336-2021-26-273-283

full text

1. Jacobsen L, Madsen P, Moestrup SK, Lund AH, Tommerup N, Nykjaer A, et al. Molecular characterization of a novel human hybrid-type receptor that binds the alpha2-macroglobulin receptor-associated protein. J Biol Chem. 1996;271(49):31379-31383. doi: 10.1074/jbc.271.49.31379.
2. Sakai S, Nakaseko C, Takeuchi M, Ohwada C, Shimizu N, Tsukamoto S, et al. Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias. Clin Chim Acta. 2012;413(19-20):1542-1548. doi: 10.1016/j.cca.2012.06.025.
3. Yan WH, Jiang XN, Wang WG, Sun YF, Wo YX, Luo ZZ, et al. Cell-of-origin subtyping of diffuse large B-cell lymphoma by using a qPCR-based gene expression assay on formalin-fixed paraffin-embedded tissues. Front Oncol. 2020;10:e803. doi: 10.3389/fonc.2020.00803.
4. Fujimura K, Ebinuma H, Fukamachi I, Ohwada C, Kawaguchi T, Shimizu N, et al. Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma. Clin Chim Acta. 2014;430(20):48-54. doi: 10.1016/j.cca.2013.12.039.
5. Krzeminski P, Corchete LA, Garcia JL, Lopez-Corral L, Ferminan E, Garcia EM, et al. Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse. Oncotarget. 2016;7(49):80664-80679. doi: 10.18632/oncotarget.13025.
6. McCaw L, Shi Y, Wang G, Li YJ, Spaner DE. Low density lipoproteins amplify cytokine-signaling in chronic lymphocytic leukemia cells. EBioMedicine. 2017;15:24-35. doi: 10.1016/j.ebiom.2016.11.033.
7. Ciarlo E, Massone S, Penna I, Nizzari M, Gigoni A, Dieci G, et al. An intronic ncRNA-dependent regulation of SORL1 expression affecting Abeta formation is upregulated in post-mortem Alzheimer's disease brain samples. Dis Model Mech. 2013;6(2):424-433. doi: 10.1242/dmm.009761.
8. Blechingberg J, Poulsen ASA, Kjolby M, Monti G, Allen M, Ivarsen AK, et al. An alternative transcript of the Alzheimer's disease risk gene SORL1 encodes a truncated receptor. Neurobiol Aging. 2018;71(266):e11-266.e24. doi: 10.1016/j.neurobiolaging.2018.06.021.
9. Grear KE, Ling IF, Simpson JF, Furman JL, Simmons CR, Peterson SL, et al. Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain. Mol Neurodegener. 2009;4:e46. doi: 10.1186/1750-1326-4-46.
10. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46(2):219-234.
11. Rai KR. A critical analysis of staging in CLL. Chronic lymphocytic leukemia. Recent progress and future direction. NewYork; 1987. 253 p.
12. Binet JL, Auguier A, Dighiero G. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariant survival analysis. Cancer. 1981;48(1):198-205.
13. International Workshop on Chronic Lymphocytic Leukemia. Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. Ann Intern Med. 1989;110:236-238.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
15. Abramenko I, Bilous N, Chumak A, Davidova E, Kryachok I, Martina Z, et al. Chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chernobyl NPP accident with focus on immunoglobulin heavy chain gene analysis. Leuk Res. 2008;32(4):535-45. doi: 10.1016/j.leukres.2007.08.013.
16. Bilous NI, Abramenko IV, Chumak AA, Dyagil IS, Martina ZV, Saenko V, Bazyka DA. The spectrum of TP53, SF3B1, and notch1 mutations in chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chornobyl NPP accident. Probl Radiac Med Radiobiol. 2018;23:283-301. doi: 10.33145/2304-8336-2018-23-283-301.
17. Zhang X, Dormady SP, Basch RS. Identification of four human cDNAs that are differentially expressed by early hematopoietic progenitors. Exp Hematology. 2000;28(11):1286-1296. doi: 10.1016/s0301-472x(00)00539-7.
18. Sugita Y, Ohwada C, Kawaguchi T, Muto T, Tsukamoto S, Takeda Y, et al. Prognostic impact of serum soluble LR11 in newly diagnosed diffuse large B-cell lymphoma: A multicenter prospective analysis. Clin Chim Acta. 2016;463(1):47-52. doi: 10.1016/j.cca.2016.10.008.
19. Ohwada C, Yamazaki A, Kawaguchi T, Sugita Y, Takeuchi M, Shimizu N, et al. Serum soluble LR11, a novel tumor derived biomarker associated with the outcome of patients with diffuse large B-cell lymphoma. Leuk Lymphoma. 2015;56(10):2982-2985. doi: 10.3109/10428194.2015.1016930.
20. Kawaguchi T, Ohwada C, Takeuchi M, Shimizu N, Sakaida E, Takeda Y, et al. Potential utility of serum soluble LR11 as a diagnostic biomarker for intravascular large B-cell lymphoma. Leuk Lymphoma. 2014;55(10):2391-2394. doi: 10.3109/10428194.2014.880430.